Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain
Open Access
- 12 June 2024
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (10) , 1033.e1-1033.e8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamideBone Marrow Transplantation, 2021
- Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experienceHematology, Transfusion and Cell Therapy, 2021
- A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2020
- Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 StudyClinical Infectious Diseases, 2020
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guidelineClinical Microbiology and Infection, 2018
- A Review of the Clinical Pharmacokinetics and Pharmacodynamics of IsavuconazoleEuropean Journal of Drug Metabolism and Pharmacokinetics, 2017
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisThe Lancet Infectious Diseases, 2016
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialThe Lancet, 2016
- Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2011
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008